Moderna
MRNA
£19.78
Share price
-2.09%
Change (1 day)
-76.29%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Market capitalization of Moderna (MRNA)
Market cap: £7.64 Billion
As of April 2025 Moderna has a market cap of £7.64 Billion. This makes Moderna the world's 1616th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Moderna from 2018 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | £7.64 B | -37.86% |
| 2024 | £12.30 B | -58.65% |
| 2023 | £29.76 B | -47.82% |
| 2022 | £57.03 B | -25.23% |
| 2021 | £76.28 B | 151.54% |
| 2020 | £30.32 B | 504.16% |
| 2019 | £5.01 B | 26.92% |
| 2018 | £3.95 B |
End of Day market cap according to different sources
On Apr 15th, 2025 the market cap of Moderna was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | £97.37 M | -98.73% | 🇺🇸 USA |
 | £148.69 B | 1,844.41% | 🇺🇸 USA |
 | £0.62 M | -99.99% | 🇺🇸 USA |
 | £22.53 B | 194.61% | 🇺🇸 USA |
 | £164.54 B | 2,051.65% | 🇨🇭 Switzerland |
 | £1.33 B | -82.58% | 🇺🇸 USA |
 | £279.06 B | 3,549.10% | 🇺🇸 USA |
 | £2.24 B | -70.65% | 🇺🇸 USA |